Literature DB >> 28476640

Pathophysiology in the comorbidity of Bipolar Disorder and Alzheimer's Disease: pharmacological and stem cell approaches.

Juliana C Corrêa-Velloso1, Maria Cb Gonçalves2, Yahaira Naaldijk1, Ágatha Oliveira-Giacomelli1, Micheli M Pillat1, Henning Ulrich3.   

Abstract

Neuropsychiatric disorders involve various pathological mechanisms, resulting in neurodegeneration and brain atrophy. Neurodevelopmental processes have shown to be critical for the progression of those disorders, which are based on genetic and epigenetic mechanisms as well as on extrinsic factors. We review here common mechanisms underlying the comorbidity of Bipolar Disorders and Alzheimer's Disease, such as aberrant neurogenesis and neurotoxicity, reporting current therapeutic approaches. The understanding of these mechanisms precedes stem cell-based strategies as a new therapeutic possibility for treatment and prevention of Bipolar and Alzheimer's Disease progression. Taking into account the difficulty of studying the molecular basis of disease progression directly in patients, we also discuss the importance of stem cells for effective drug screening, modeling and treating psychiatric diseases, once in vitro differentiation of patient-induced pluripotent stem cells provides relevant information about embryonic origins, intracellular pathways and molecular mechanisms.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's Disease; Bipolar Disorder; Lithium; Memantine; Stem cell therapy

Mesh:

Year:  2017        PMID: 28476640     DOI: 10.1016/j.pnpbp.2017.04.033

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  7 in total

1.  Add-On Memantine Treatment for Bipolar II Disorder Comorbid with Alcohol Dependence: A 12-Week Follow-Up Study.

Authors:  Sheng-Yu Lee; Tzu-Yun Wang; Shiou-Lan Chen; Yun-Hsuan Chang; Po-See Chen; San-Yuan Huang; Nian-Sheng Tzeng; Liang-Jen Wang; I Hui Lee; Kao Ching Chen; Yen Kuang Yang; Jau-Shyong Hong; Ru-Band Lu
Journal:  Alcohol Clin Exp Res       Date:  2018-05-17       Impact factor: 3.455

2.  Stem cells and mechanisms regulating their trafficking - a new and challenging area of investigation in modern psychiatry.

Authors:  Mariusz Z Ratajczak
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2018-01-03       Impact factor: 5.067

Review 3.  Induced pluripotent stem cells for neural drug discovery.

Authors:  Atena Farkhondeh; Rong Li; Kirill Gorshkov; Kevin G Chen; Matthew Might; Steven Rodems; Donald C Lo; Wei Zheng
Journal:  Drug Discov Today       Date:  2019-01-18       Impact factor: 7.851

4.  Multivariate analysis of genome-wide data to identify potential pleiotropic genes for five major psychiatric disorders using MetaCCA.

Authors:  XiaoCan Jia; YongLi Yang; YuanCheng Chen; ZhiWei Cheng; Yuhui Du; Zhenhua Xia; Weiping Zhang; Chao Xu; Qiang Zhang; Xin Xia; HongWen Deng; XueZhong Shi
Journal:  J Affect Disord       Date:  2018-07-17       Impact factor: 4.839

5.  Long-term Treatment with Low-Dose Caffeine Worsens BPSD-Like Profile in 3xTg-AD Mice Model of Alzheimer's Disease and Affects Mice with Normal Aging.

Authors:  Raquel Baeta-Corral; Björn Johansson; Lydia Giménez-Llort
Journal:  Front Pharmacol       Date:  2018-02-15       Impact factor: 5.810

6.  Current status and future prospects of stem cell therapy in Alzheimer's disease.

Authors:  Fu-Qiang Zhang; Jin-Lan Jiang; Jing-Tian Zhang; Han Niu; Xue-Qi Fu; Lin-Lin Zeng
Journal:  Neural Regen Res       Date:  2020-02       Impact factor: 5.135

Review 7.  Flavonoids as Therapeutic Agents in Alzheimer's and Parkinson's Diseases: A Systematic Review of Preclinical Evidences.

Authors:  Roxana Braga de Andrade Teles; Tâmara Coimbra Diniz; Tiago Coimbra Costa Pinto; Raimundo Gonçalves de Oliveira Júnior; Mariana Gama E Silva; Érica Martins de Lavor; Antonio Wilton Cavalcante Fernandes; Ana Paula de Oliveira; Fernanda Pires Rodrigues de Almeida Ribeiro; Amanda Alves Marcelino da Silva; Taisy Cinthia Ferro Cavalcante; Lucindo José Quintans Júnior; Jackson Roberto Guedes da Silva Almeida
Journal:  Oxid Med Cell Longev       Date:  2018-05-10       Impact factor: 6.543

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.